DK1818052T3 - Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre - Google Patents

Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre

Info

Publication number
DK1818052T3
DK1818052T3 DK05763090.7T DK05763090T DK1818052T3 DK 1818052 T3 DK1818052 T3 DK 1818052T3 DK 05763090 T DK05763090 T DK 05763090T DK 1818052 T3 DK1818052 T3 DK 1818052T3
Authority
DK
Denmark
Prior art keywords
formoterol
prophylactic
diabetes
aids
cancer
Prior art date
Application number
DK05763090.7T
Other languages
English (en)
Inventor
Huguet Jose Maria Argiles
Soriano Francisco Javier Lopez
Rius Silvia Busquets
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Application granted granted Critical
Publication of DK1818052T3 publication Critical patent/DK1818052T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK05763090.7T 2004-06-29 2005-06-28 Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre DK1818052T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401941A ES2245612B1 (es) 2004-06-29 2004-06-29 Nuevo uso terapeutico del formoterol.
PCT/ES2005/000365 WO2006003222A1 (es) 2004-06-29 2005-06-28 Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras

Publications (1)

Publication Number Publication Date
DK1818052T3 true DK1818052T3 (da) 2010-03-29

Family

ID=35614437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05763090.7T DK1818052T3 (da) 2004-06-29 2005-06-28 Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre

Country Status (9)

Country Link
EP (1) EP1818052B1 (da)
AT (1) ATE447944T1 (da)
CY (1) CY1109771T1 (da)
DE (1) DE602005017659D1 (da)
DK (1) DK1818052T3 (da)
ES (2) ES2245612B1 (da)
PL (1) PL1818052T3 (da)
PT (1) PT1818052E (da)
WO (1) WO2006003222A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
JP5627452B2 (ja) * 2007-04-24 2014-11-19 アカシア ファーマ リミテッドＡｃａｃｉａ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 筋肉減少の治療に使用される薬剤の組合せ
CN117562998A (zh) * 2023-02-02 2024-02-20 上海市第十人民医院 长效β2AR激动剂在制备治疗癌症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
AU2002252950A1 (en) * 2001-02-22 2002-09-04 Universitatsklinikum Charite Medizinische Fakultat Der Humboldt-Universitat Zu Berlin Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis

Also Published As

Publication number Publication date
CY1109771T1 (el) 2014-09-10
WO2006003222A1 (es) 2006-01-12
PL1818052T3 (pl) 2010-04-30
EP1818052B1 (en) 2009-11-11
ES2336229T3 (es) 2010-04-09
ES2245612B1 (es) 2007-08-16
WO2006003222A9 (es) 2009-01-15
PT1818052E (pt) 2010-02-15
EP1818052A1 (en) 2007-08-15
ES2245612A1 (es) 2006-01-01
DE602005017659D1 (de) 2009-12-24
ATE447944T1 (de) 2009-11-15

Similar Documents

Publication Publication Date Title
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
MXPA04000647A (es) Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
WO2006017188A3 (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
CR8273A (es) Administracion de ligandos de tlr7 y profarmacos de los mismos para el tratamiento de la infeccion por el virus de hepetitis c
RU2013119607A (ru) Полициклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
WO2007057763A3 (en) Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
ECSP055844A (es) Nuevos compuestos triciclicos
EA201300421A1 (ru) Комбинированная терапия для лечения инфекции hcv
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
DK1818052T3 (da) Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre
DE602005010844D1 (de) Pharmazeutische zusammensetzungen mit interferon-tau
DK1670489T3 (da) Brug af xenon med hypotermi til behandling af neonatal asfyksi
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
ZA200703237B (en) Pharmaceutical agents comprising blood components <10 KDA and their use for prophylaxis and treatment of defects of the immune system
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
DK1350510T3 (da) Anvendelse af et middelt til undertrykkelse af infektion og proliferation af humant immundefektvirus